Project Grant R21TW013266
Award Date 9/1/26
Completion Date 6/30/28
Dollars Obligated $189K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Notre Dame, IN 46556, USA
Similar Awards
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Makerere University College of Health Sciences $137,008 on August 15, 2026, under the International Research and Research Training program (CFDA 93.989) to build research training capacity in schistosomiasis in Uganda. The award funds a comprehensive collaborative multi-disciplinary schistosomiasis research training program comprising modular short courses and a focused cohort of...
- The National Science Foundation Division of Environmental Biology awarded the University of Notre Dame DU Lac $130,000 on May 1, 2026, under the Biological Sciences program (CFDA 47.074) to support years 31–35 of the Kenya Long-Term Exclosure Experiment (KLEE), a controlled, replicated field study of livestock, wildlife, and fire interactions in savanna rangeland ecosystems. The research examines how cattle, meso-herbivore wildlife, and mega-herbivores (elephants and giraffes) compete,...
- This $196,163 federal Project Grant award from the National Science Foundation (NSF) under the Mathematical and Physical Sciences program (CFDA 47.049) is funding a collaborative research project on developing advanced mathematical models to improve understanding and management of schistosomiasis transmission dynamics. The project is a collaboration between the University of Florida, University of Georgia, and University of Massachusetts, and aims to create innovative hybrid...
- The National Institute of Allergy and Infectious Diseases awarded the University of Notre Dame DU Lac $464,176 on April 3, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to evaluate species-specific yeast RNAi insecticides for sand fly control as vectors of leishmaniasis. The research evaluates the potential of RNAi yeast-based insecticides to control sand flies, particularly the genera Phlebotomus (Africa, Asia, Europe) and Lutzomyia (Americas), which transmit...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Rochester $908,204 on June 1, 2026, under the International Research and Research Training program (CFDA 93.989) to support mentored research and career development training focused on neurocognitive impairment among HIV-infected and HIV-negative meningitis patients in rural, northern Uganda. The award funds validation of neurocognitive assessment tools to determine...
- The National Institute of Allergy and Infectious Diseases awarded the University of Notre Dame DU Lac $709,532 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct systematic research into the cytoplasmic pathway for peptidoglycan recycling in Pseudomonas aeruginosa, an antibiotic-resistant gram-negative bacterial pathogen responsible for recurrent lung infections in cystic fibrosis patients. The work addresses two specific aims. The first...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Washington $417,681 on August 20, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and evaluate a Systems Analysis and Improvement Approach to optimize cardiometabolic care delivery for hypertension and type 2 diabetes in central Mozambique. The recipient will apply the SAIA implementation strategy to improve diagnosis and...
- The National Institute of Allergy and Infectious Diseases awarded Rhode Island Hospital $2.737 million on September 24, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a randomized controlled trial evaluating praziquantel treatment frequencies for schistosomiasis-related hepatic fibrosis in Uganda. Rhode Island Hospital will enroll 600 subjects aged 15–40 with compensated schistosomal fibrosis at Lake Albert, Uganda, and randomize them to receive...
- Federal Grant Award Summary The University of Notre Dame received a $125,998 Project Grant from the National Science Foundation's Office of Integrative Activities under the Geosciences program (CFDA 47.050) on August 15, 2025, with a completion date of July 31, 2028. This award supports U.S. researchers' participation in the Biorepositories Build Adaptive and Resilient Capacity (BIOARC) project, a competitively selected initiative under the Belmont Forum, a 55-country consortium focused on...
- Federal Grant Award Summary The University of Notre Dame DU Lac received a $459,439 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 7, 2025, with completion scheduled for June 30, 2027. The grant supports research addressing acute cellular rejection (ACR) in organ transplantation through investigation of CD8+ T cell alloreactivity and its relationship to viral...